Literature DB >> 25531344

Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak.

Matthew L Boisen1, John S Schieffelin, Augustine Goba, Darin Oottamasathien, Abigail B Jones, Jeffrey G Shaffer, Kathryn M Hastie, Jessica N Hartnett, Mambu Momoh, Mohammed Fullah, Michael Gabiki, Sidiki Safa, Michelle Zandonatti, Marnie Fusco, Zach Bornholdt, Dafna Abelson, Stephen K Gire, Kristian G Andersen, Ridhi Tariyal, Mathew Stremlau, Robert W Cross, Joan B Geisbert, Kelly R Pitts, Thomas W Geisbert, Peter Kulakoski, Russell B Wilson, Lee Henderson, Pardis C Sabeti, Donald S Grant, Robert F Garry, Erica O Saphire, Luis M Branco, Sheik Humarr Khan.   

Abstract

Lassa fever (LF) is a severe viral hemorrhagic fever caused by Lassa virus (LASV). The LF program at the Kenema Government Hospital (KGH) in Eastern Sierra Leone currently provides diagnostic services and clinical care for more than 500 suspected LF cases per year. Nearly two-thirds of suspected LF patients presenting to the LF Ward test negative for either LASV antigen or anti-LASV immunoglobulin M (IgM), and therefore are considered to have a non-Lassa febrile illness (NLFI). The NLFI patients in this study were generally severely ill, which accounts for their high case fatality rate of 36%. The current studies were aimed at determining possible causes of severe febrile illnesses in non-LF cases presenting to the KGH, including possible involvement of filoviruses. A seroprevalence survey employing commercial enzyme-linked immunosorbent assay tests revealed significant IgM and IgG reactivity against dengue virus, chikungunya virus, West Nile virus (WNV), Leptospira, and typhus. A polymerase chain reaction-based survey using sera from subjects with acute LF, evidence of prior LASV exposure, or NLFI revealed widespread infection with Plasmodium falciparum malaria in febrile patients. WNV RNA was detected in a subset of patients, and a 419 nt amplicon specific to filoviral L segment RNA was detected at low levels in a single patient. However, 22% of the patients presenting at the KGH between 2011 and 2014 who were included in this survey registered anti-Ebola virus (EBOV) IgG or IgM, suggesting prior exposure to this agent. The 2014 Ebola virus disease (EVD) outbreak is already the deadliest and most widely dispersed outbreak of its kind on record. Serological evidence reported here for possible human exposure to filoviruses in Sierra Leone prior to the current EVD outbreak supports genetic analysis that EBOV may have been present in West Africa for some time prior to the 2014 outbreak.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25531344      PMCID: PMC4287116          DOI: 10.1089/vim.2014.0108

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  44 in total

Review 1.  Ribavirin--current status of a broad spectrum antiviral agent.

Authors:  N J Snell
Journal:  Expert Opin Pharmacother       Date:  2001-08       Impact factor: 3.889

2.  Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA.

Authors:  Stephan Olschläger; Michaela Lelke; Petra Emmerich; Marcus Panning; Christian Drosten; Meike Hass; Danny Asogun; Deborah Ehichioya; Sunday Omilabu; Stephan Günther
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

3.  Emergence of Zaire Ebola virus disease in Guinea.

Authors:  Sylvain Baize; Delphine Pannetier; Lisa Oestereich; Toni Rieger; Lamine Koivogui; N'Faly Magassouba; Barrè Soropogui; Mamadou Saliou Sow; Sakoba Keïta; Hilde De Clerck; Amanda Tiffany; Gemma Dominguez; Mathieu Loua; Alexis Traoré; Moussa Kolié; Emmanuel Roland Malano; Emmanuel Heleze; Anne Bocquin; Stephane Mély; Hervé Raoul; Valérie Caro; Dániel Cadar; Martin Gabriel; Meike Pahlmann; Dennis Tappe; Jonas Schmidt-Chanasit; Benido Impouma; Abdoul Karim Diallo; Pierre Formenty; Michel Van Herp; Stephan Günther
Journal:  N Engl J Med       Date:  2014-04-16       Impact factor: 91.245

4.  Development of species-specific PCR primer sets for the detection of Leptospira.

Authors:  Raven E Reitstetter
Journal:  FEMS Microbiol Lett       Date:  2006-11       Impact factor: 2.742

5.  Epidemiology and control of frontier malaria in Brazil: lessons from community-based studies in rural Amazonia.

Authors:  Natal S da Silva; M da Silva-Nunes; Rosely S Malafronte; Maria J Menezes; Rosane R D'Arcadia; Natália T Komatsu; Kézia K G Scopel; Erika M Braga; Carlos E Cavasini; José A Cordeiro; Marcelo U Ferreira
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-01-27       Impact factor: 2.184

6.  Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report.

Authors:  Luis M Branco; Matt L Boisen; Kristian G Andersen; Jessica N Grove; Lina M Moses; Ivana J Muncy; Lee A Henderson; John S Schieffellin; James E Robinson; James J Bangura; Donald S Grant; Vanessa N Raabe; Mbalu Fonnie; Eleina M Zaitsev; Pardis C Sabeti; Robert F Garry
Journal:  Virol J       Date:  2011-08-15       Impact factor: 4.099

7.  Pathogenesis of Lassa fever in cynomolgus macaques.

Authors:  Lisa E Hensley; Mark A Smith; Joan B Geisbert; Elizabeth A Fritz; Kathleen M Daddario-DiCaprio; Tom Larsen; Thomas W Geisbert
Journal:  Virol J       Date:  2011-05-06       Impact factor: 4.099

Review 8.  Applications of next-generation sequencing technologies to diagnostic virology.

Authors:  Luisa Barzon; Enrico Lavezzo; Valentina Militello; Stefano Toppo; Giorgio Palù
Journal:  Int J Mol Sci       Date:  2011-11-14       Impact factor: 5.923

9.  Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report.

Authors:  Jessica N Grove; Luis M Branco; Matt L Boisen; Ivana J Muncy; Lee A Henderson; John S Schieffellin; James E Robinson; James J Bangura; Mbalu Fonnie; Randal J Schoepp; Lisa E Hensley; Alhassan Seisay; Joseph N Fair; Robert F Garry
Journal:  Virol J       Date:  2011-06-20       Impact factor: 4.099

10.  Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection.

Authors:  Luis M Branco; Jessica N Grove; Matt L Boisen; Jeffrey G Shaffer; Augustine Goba; Mohammed Fullah; Mambu Momoh; Donald S Grant; Robert F Garry
Journal:  Virol J       Date:  2011-10-24       Impact factor: 4.099

View more
  20 in total

1.  Ebola Virus Disease: Rapid Diagnosis and Timely Case Reporting are Critical to the Early Response for Outbreak Control.

Authors:  Lola V Stamm
Journal:  Am J Trop Med Hyg       Date:  2015-07-14       Impact factor: 2.345

2.  Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus.

Authors:  Verena Krähling; Dirk Becker; Cornelius Rohde; Markus Eickmann; Yonca Eroğlu; Astrid Herwig; Romy Kerber; Katharina Kowalski; Júlia Vergara-Alert; Stephan Becker
Journal:  Med Microbiol Immunol       Date:  2015-10-16       Impact factor: 3.402

3.  Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.

Authors:  Robert W Cross; Matthew L Boisen; Molly M Millett; Diana S Nelson; Darin Oottamasathien; Jessica N Hartnett; Abigal B Jones; Augustine Goba; Mambu Momoh; Mohamed Fullah; Zachary A Bornholdt; Marnie L Fusco; Dafna M Abelson; Shunichiro Oda; Bethany L Brown; Ha Pham; Megan M Rowland; Krystle N Agans; Joan B Geisbert; Megan L Heinrich; Peter C Kulakosky; Jeffrey G Shaffer; John S Schieffelin; Brima Kargbo; Momoh Gbetuwa; Sahr M Gevao; Russell B Wilson; Erica Ollmann Saphire; Kelly R Pitts; Sheik Humarr Khan; Donald S Grant; Thomas W Geisbert; Luis M Branco; Robert F Garry
Journal:  J Infect Dis       Date:  2016-08-31       Impact factor: 5.226

4.  Surveillance of Vector-Borne Infections (Chikungunya, Dengue, and Malaria) in Bo, Sierra Leone, 2012-2013.

Authors:  Donald F Dariano; Chris R Taitt; Kathryn H Jacobsen; Umaru Bangura; Alfred S Bockarie; Moses J Bockarie; Joseph Lahai; Joseph M Lamin; Tomasz A Leski; Chadwick Yasuda; David A Stenger; Rashid Ansumana
Journal:  Am J Trop Med Hyg       Date:  2017-10       Impact factor: 2.345

Review 5.  Epidemiology and Management of the 2013-16 West African Ebola Outbreak.

Authors:  M L Boisen; J N Hartnett; A Goba; M A Vandi; D S Grant; J S Schieffelin; R F Garry; L M Branco
Journal:  Annu Rev Virol       Date:  2016-08-15       Impact factor: 10.431

6.  Development of Prototype Filovirus Recombinant Antigen Immunoassays.

Authors:  Matt L Boisen; Darin Oottamasathien; Abigail B Jones; Molly M Millett; Diana S Nelson; Zachary A Bornholdt; Marnie L Fusco; Dafna M Abelson; Shun-Ichiro Oda; Jessica N Hartnett; Megan M Rowland; Megan L Heinrich; Marjan Akdag; Augustine Goba; Mambu Momoh; Mohammed Fullah; Francis Baimba; Michael Gbakie; Sadiki Safa; Richard Fonnie; Lansana Kanneh; Robert W Cross; Joan B Geisbert; Thomas W Geisbert; Peter C Kulakosky; Donald S Grant; Jeffery G Shaffer; John S Schieffelin; Russell B Wilson; Erica Ollmann Saphire; Luis M Branco; Robert F Garry; S Humarr Khan; Kelly R Pitts
Journal:  J Infect Dis       Date:  2015-07-30       Impact factor: 5.226

7.  Ebola viral load at diagnosis associates with patient outcome and outbreak evolution.

Authors:  Marc-Antoine de La Vega; Grazia Caleo; Jonathan Audet; Xiangguo Qiu; Robert A Kozak; James I Brooks; Steven Kern; Anja Wolz; Armand Sprecher; Jane Greig; Kamalini Lokuge; David K Kargbo; Brima Kargbo; Antonino Di Caro; Allen Grolla; Darwyn Kobasa; James E Strong; Giuseppe Ippolito; Michel Van Herp; Gary P Kobinger
Journal:  J Clin Invest       Date:  2015-11-09       Impact factor: 14.808

8.  An Outbreak of Ebola Virus Disease in the Lassa Fever Zone.

Authors:  Augustine Goba; S Humarr Khan; Mbalu Fonnie; Mohamed Fullah; Alex Moigboi; Alice Kovoma; Vandi Sinnah; Nancy Yoko; Hawa Rogers; Siddiki Safai; Mambu Momoh; Veronica Koroma; Fatima K Kamara; Edwin Konowu; Mohamed Yillah; Issa French; Ibraham Mustapha; Franklyn Kanneh; Momoh Foday; Helena McCarthy; Tiangay Kallon; Mustupha Kallon; Jenneh Naiebu; Josephine Sellu; Abdul A Jalloh; Michael Gbakie; Lansana Kanneh; James L B Massaly; David Kargbo; Brima Kargbo; Mohamed Vandi; Momoh Gbetuwa; Sahr M Gevao; John D Sandi; Simbirie C Jalloh; Donald S Grant; Sylvia O Blyden; Ian Crozier; John S Schieffelin; Susan L McLellan; Shevin T Jacob; Matt L Boisen; Jessica N Hartnett; Robert W Cross; Luis M Branco; Kristian G Andersen; Nathan L Yozwiak; Stephen K Gire; Ridhi Tariyal; Daniel J Park; Allyson M Haislip; Christopher M Bishop; Lilia I Melnik; William R Gallaher; William C Wimley; Jing He; Jeffrey G Shaffer; Brian M Sullivan; Sonia Grillo; Scott Oman; Courtney E Garry; Donna R Edwards; Stephanie J McCormick; Deborah H Elliott; Julie A Rouelle; Chandrika B Kannadka; Ashley A Reyna; Benjamin T Bradley; Haini Yu; Rachael E Yenni; Kathryn M Hastie; Joan B Geisbert; Peter C Kulakosky; Russell B Wilson; Michael B A Oldstone; Kelly R Pitts; Lee A Henderson; James E Robinson; Thomas W Geisbert; Erica Ollmann Saphire; Christian T Happi; Danny A Asogun; Pardis C Sabeti; Robert F Garry
Journal:  J Infect Dis       Date:  2016-07-11       Impact factor: 5.226

9.  Circulating microRNA profiles of Ebola virus infection.

Authors:  Janice Duy; Jeffrey W Koehler; Anna N Honko; Randal J Schoepp; Nadia Wauquier; Jean-Paul Gonzalez; M Louise Pitt; Eric M Mucker; Joshua C Johnson; Aileen O'Hearn; James Bangura; Moinya Coomber; Timothy D Minogue
Journal:  Sci Rep       Date:  2016-04-21       Impact factor: 4.379

10.  Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali.

Authors:  Nafomon Sogoba; Kyle Rosenke; Jennifer Adjemian; Sory Ibrahim Diawara; Ousmane Maiga; Moussa Keita; Drissa Konaté; Abdoul Salam Keita; Ibrahim Sissoko; Matt Boisen; Diana Nelson; Darin Oottamasathien; Molly Millett; Robert F Garry; Luis M Branco; Sékou F Traoré; Seydou Doumbia; Heinz Feldmann; David Safronetz
Journal:  Emerg Infect Dis       Date:  2016-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.